Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
International Journal of Cancer|September 19, 2020
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot studyMatthias Unseld, Jelena Belic, Kerstin Pierer, et al.
Plos One|August 19, 2014
Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patientsMichael Stotz, Joanna Szkandera, Julia Seidel, et al.
American Journal of Surgery|March 4, 2014
The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patientsJoanna Szkandera, Martin Pichler, Gudrun Absenger, et al.
Oncotarget|December 10, 2017
Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line settingJakob Michael Riedl, Florian Posch, Florian Moik, et al.
Clinical Chemistry and Laboratory Medicine|October 12, 2018
Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancerAnna L Lembeck, Florian Posch, Eva V Klocker, et al.
Wiener Klinische Wochenschrift|August 23, 2018
Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysisEva Asamer, Joanna Szkandera, Paul Gibiser, et al.
Pharmacogenetics and Genomics|November 8, 2014
Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancerAna Sebio, Armin Gerger, Satoshi Matsusaka, et al.
Cancer Medicine|June 16, 2020
External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patientsDominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, et al.
RNA Biology|December 5, 2022
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon responseFelix Prinz, Katharina Jonas, Amar Balihodzic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2010
Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patientsThomas Winder, Wu Zhang, Dongyun Yang, et al.
Pageof 16